Latest in Craters Trial
Sort by
9 items
-
Georgia Push to Curb Lawsuits Puts Business Groups and Trial Lawyers at Odds
A political push from Gov. Brian Kemp to reduce the number of civil lawsuits is incurring a major backlash from Georgia’s trial lawyers, who say the number of lawsuits isn’t the reason for rising ...Inc. - 4h -
-
Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact
At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss ...MarketWatch - 9h -
Could fandom cause jury nullification in Luigi Mangione trial?
With overwhelming evidence against Mangione, jury nullification could be what gets him acquitted or the result of a mistrial.The Hill - 1d -
Trial Starts for Nicolas Sarkozy in Libya Election Case
The former French president has faced several legal cases since leaving office, but accusations that he received money for his 2007 election from Libyan authorities have been particularly damaging.The New York Times - 2d -
Donald Trump is walking into a slew of trials and tribulations
When Donald Trump takes the oath of office for the second time in two weeks, he will face a nearly impossible task of governing effectively.The Hill - 2d -
Nicolas Sarkozy goes on trial accused of receiving illegal funding from Gaddafi
Former French president alleged to have received millions of euros from Libyan dictator’s regime to fund campaign. Nicolas Sarkozy has gone on trial over allegations he received millions of euros ...The Guardian - 2d -
France's former President Sarkozy standing trial over alleged campaign funding by Libya's Gadhafi
France’s former President Nicolas Sarkozy goes on trial Monday over alleged illegal financing of his 2007 presidential campaign by the government of late Libyan leader Moammar GadhafiABC News - 2d -
Neumora Therapeutics’ stock craters after trial of major depressive disorder fails to meet main goals
The news is a setback for the clinical-stage biotech and a drug that proved successful in earlier trials.MarketWatch - 6d
